Skip to main content
Advertisement
Advertisement

CAPR

CAPR logo

Capricor Therapeutics Inc

8.57
USD
Sponsored
-0.10
-1.15%
Sep 24, 15:59 UTC -4
Closed
exchange

Pre-Market

8.70

+0.13
+1.52%

CAPR Earnings Reports

Positive Surprise Ratio

CAPR beat 22 of 40 last estimates.

55%

Next Report

Date of Next Report
Nov 09, 2026
Estimate for Q3 26 (Revenue/ EPS)
$42.78M
/
-$0.43
Implied change from Q2 26 (Revenue/ EPS)
--
/
-38.57%
Implied change from Q3 25 (Revenue/ EPS)
--
/
-20.37%

Capricor Therapeutics Inc earnings per share and revenue

On Aug 13, 2026, CAPR reported earnings of -0.70 USD per share (EPS) for Q2 26, missing the estimate of -0.60 USD, resulting in a -16.32% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +57.96% price change (close before vs. close after earnings).
Looking ahead to Q3 26, -- analysts forecast an EPS of -0.43 USD, with revenue projected to reach 42.78 million USD, implying an decrease of -38.57% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Kestra Medical Technologies, Ltd. Common Stock
Report Date
Sep 14, 2026 For Q1 27
Estimate
-$0.62
Actual
-$0.65
Surprise
-3.47%
logo
High Tide Inc. Common Shares
Report Date
Sep 14, 2026 For Q3 26
Estimate
$0.01
Actual
$0.12
Surprise
+1,088.12%
FAQ
For Q2 2026, Capricor Therapeutics Inc reported EPS of -$0.70, missing estimates by -16.32%, and revenue of $0.00, 0% as expectations.
The stock price moved up 57.96%, changed from $4.21 before the earnings release to $6.65 the day after.
The next earning report is scheduled for Nov 09, 2026.
Based on -- analysts, Capricor Therapeutics Inc is expected to report EPS of -$0.43 and revenue of $42.78M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement